Last Updated on October 17, 2024 by The Health Master
USFDA approval
Zydus Lifesciences Limited has reached a significant milestone with the recent final USFDA approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isosorbide Mononitrate Extended-Release Tablets USP in 30 mg, 60 mg, and 120 mg variants.
This achievement, announced on a Friday, marks a pivotal moment for the company and the pharmaceutical industry as a whole.
Understanding Isosorbide Mononitrate’s Role
Isosorbide mononitrate plays a crucial role in preventing chest pain (angina) in patients with coronary artery disease.
This medication, known for its efficacy, is specifically designed to cater to a targeted patient group, making it an essential component in managing heart conditions.
Exploring Zydus Lifesciences Limited
Zydus Lifesciences Limited, a key player in the pharmaceutical sector, has consistently demonstrated its commitment to innovation and quality.
With 388 USFDA approvals to its name and over 460 Abbreviated New Drug Applications (ANDAs) filed since the initiation of the filing process in FY 2003-04, the company has been a trailblazer in the industry.
Navigating the USFDA Approval Process
The USFDA approval process is known for its rigorous standards and requirements, ensuring the safety and efficacy of pharmaceutical products.
Zydus Lifesciences Limited’s successful navigation through this process not only highlights the company’s dedication to quality but also opens new avenues for product distribution and market reach.
Insights into the Regulatory Landscape in Pharmaceuticals
Understanding the role of regulatory bodies, such as the USFDA, is crucial in comprehending the challenges and benefits associated with compliance.
Zydus Lifesciences Limited‘s achievement reflects not only the company’s capability but also the effectiveness of regulatory oversight in ensuring the safety and efficacy of pharmaceuticals.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
The Future of Drug Approval: Embracing the USFDA’s RRA
USFDA Approval granted for Generic Dronedarone Tablets
USFDA approval granted for Pregabalin capsule: Strides Pharma
10 Facts about USFDA Approval of Drug
USFDA approval granted for generic Pregabalin Capsules: Strides
Unlocking the Potential: E-Pharmacy and the Future of Indian Healthcare
DCA cancels Mylan’s permission to manufacture Alprazolam: Telangana
DCGI to Collaborate with Stakeholders: Empowering Ease of Doing Business
Govt extends Deadline for Industry for AMD-CF Scheme
FDA Maharashtra: Action Against Illicit Drug Sales
FSSAI: Food Labelling and Display – Chapter-2
DCGI issues Guidelines on Sampling of Drugs
Investigation into Brand Names of drugs Confusion
USFDA grants VAI classification to Dr Reddy’s R&D centre
The Future of Drug Approval: Embracing the USFDA’s RRA
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
